“Volume in Numbers…
Power from Volume”
Find Out MoreOur sites and Social Media platforms act as a podium for your company to talk to their audience – consumers.
We provide many portals for companies to host fully loaded comprehensive profiles, animated banner ads describing your company and its products in their true light, Videos, Business Plans, Executive Summaries, and PowerPoints. All of these features are provided free to the end user with no fees making it easy for your company to communicate and share resources with potential and active clients and consumers.

Planning, making strategies…
After successfull campaign…
Case Studies
Client Testimonials
News
- Alpha Modus (NASDAQ: AMOD) CEO Doubles Down with $3M Commitment Amid Execution Milestones and Imminent Revenue Surge
- Alpha Modus (NASDAQ: AMOD) CEO Doubles Down with $3M Commitment Amid Execution Milestones and Imminent Revenue Surge
- Alpha Modus Expands CashX Rollout via Strategic U.S. Reseller Agreement with Genmega
- ZenaTech’s ZenaDrone Launches the IQ Nano Indoor Drone for US Defense Applications and Initiates Green and Blue UAS Certifications
- Alpha Modus Featured in International Business Times
- Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by New to The Street TV.
- How Much Weight Can Drones Carry?
- 2025 Virtual Tech Conference
- ZenaTech’s ZenaDrone to File Patent and Accelerate Deployment of Counter-UAS Technology on the ZenaDrone 1000 in Response to US Executive Order
- Historic Executive Order Fast-Tracks ZenaTech’s ZenaDrone Subsidiary Manufacturing and Go-to-Market Plans for Dual-Use Defense and Commercial Drones
- ZenaTech Launches Drone as a Service (DaaS) for US Defense and Government Agencies with New Partnerships
- RMX (Reticulate Micro) Secures GSA Schedule Placement, Enhancing Government Market Access
- IQSTD - IQSTEL Reports Strong Preliminary Q1 2025 Results: Revenue Growth, Margin Expansion, and Strategic Progress Toward NASDAQ Uplisting
- Genprex Signs Exclusive License to Additional Gene Therapy Technology with UTHealth Houston for the Treatment of Glioblastoma
- Reticulate Micro’s VAST Platform to Power Advanced Tactical Video at SOF Week 2025